Health ❯ Healthcare

Regulatory Agencies

FDA Anvisa MHRA European Medicines Agency Drug Approval Process Food and Drug Administration ANSM Drug Safety Drug Approval ANMAT

HHS Names Permanent Heads for FDA Drug, Biologics and Tobacco Centers

The appointments are meant to steady the agency after heavy turnover, with a new deputy to centralize technology and AI policy.

Company Recalls Three Lots of Multi‑Dose Epinephrine Vials Over Contamination Concerns

FDA Works With Manufacturers to Expand Supply of Estradiol Menopause Patches

FDA Approves Zanvastro as First Treatment for Alexander Disease

FDA Approves Lisraya as First Oral Treatment for Adult Dermatomyositis

NICE Recommends Once-Weekly Insulin Onswik for Adults With Type 2 Diabetes

Mounjaro Study Finds Lower Heart‑Attack Risk as UK Safety Reports Rise

FDA Approves Moderna’s mFlusiva, First mRNA Flu Vaccine

Nearly 12 Million Rohto Eye Drop Cartons Recalled Over Sterility Concerns

Anvisa Orders Recall of Paramol 750 mg Lot After Tablets Show Mold-Like Spots

Anvisa Orders Seizure of Specific Falsified Mounjaro Units

UK Clears Aficamten (MYQORZO) for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Anvisa Registers Five New Semaglutide Pens

Anvisa Says Retatrutida Is Unapproved as Illegal Versions Spread

MHRA Strengthens Warnings on Botulinum Toxin After Rise in Hospitalisations

Wegovy Pill Hits UK Private Market as Safety and Access Worries Rise

Anvisa Seizes Falsified Mounjaro Lots and Bans Unregistered Supplements

More Than 2.5 Million Lupin Eye Drop Bottles Recalled Nationwide

MHRA Warns Heat Can Damage Medicines and Medical Devices

EMA Committee Recommends Revoking Tavneos Authorization